Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose The objective of this study was to determine the frequencies of different clinical presentations and the phenotypic spectrum of multiple sclerosis (MS). Methods This cross-sectional study was performed in the Neurology Department of King Fahd Hospital of University Alkhobar in the Kingdom of Saudi Arabia (KSA). Data of 190 MS patients who fulfilled the McDonald criteria were retrieved from medical records and analyzed. Results The age at disease onset was 26.27±8.2 years (mean±SD) and disease duration was 6.38±5.10 years. The male-to-female ratio was 1:1.6. Optic neuritis and myelitis were the most-frequent first clinical presentations. Sensory (73.1%), motor (61%), and visual (58.4%) symptoms were the most-frequent established clinical symptoms. Relapsing-remitting multiple sclerosis (RRMS) was present in 75% of the cases. Supratentorial T2-weighted white-matter lesions and deep-gray-matter or juxtacortical lesions were the most-frequent magnetic resonance imaging (MRI) lesions, comprising 28% and 23.7% of all MRI lesions observed in 93.6% and 79.4% of the cases, respectively. The scores on the Expanded Disability Status Scale were within the range of 1.0–5.5 in 82.1% of the patients. There were 145 (76.3%) patients taking interferon β therapy. Conclusions MS presenting in the hospital setting is more common in KSA than reported previously, and the number of diagnosed cases in increasing. It is therefore an emerging and disabling neurological illness in KSA with clinical characteristics not dissimilar to those in other middle eastern countries. A decrease in the frequency of patients with secondary progressive multiple sclerosis (SPMS) indicates either that more new cases of RRMS are being diagnosed or that adequate treatments of RRMS are preventing the evolution to SPMS. Further larger and populationwide epidemiological and clinical studies with the long-term follow-up of MS patients are required to better assess the clinical spectrum of MS in KSA.
Abstract
Background and Purpose The objective of this study was to determine the frequencies of different clinical presentations and the phenotypic spectrum of multiple sclerosis (MS). Methods This cross-sectional study was performed in the Neurology Department of King Fahd Hospital of University Alkhobar in the Kingdom of Saudi Arabia (KSA). Data of 190 MS patients who fulfilled the McDonald criteria were retrieved from medical records and analyzed. Results The age at disease onset was 26.27±8.2 years (mean±SD) and disease duration was 6.38±5.10 years. The male-to-female ratio was 1:1.6. Optic neuritis and myelitis were the most-frequent first clinical presentations. Sensory (73.1%), motor (61%), and visual (58.4%) symptoms were the most-frequent established clinical symptoms. Relapsing-remitting multiple sclerosis (RRMS) was present in 75% of the cases. Supratentorial T2-weighted white-matter lesions and deep-gray-matter or juxtacortical lesions were the most-frequent magnetic resonance imaging (MRI) lesions, comprising 28% and 23.7% of all MRI lesions observed in 93.6% and 79.4% of the cases, respectively. The scores on the Expanded Disability Status Scale were within the range of 1.0–5.5 in 82.1% of the patients. There were 145 (76.3%) patients taking interferon β therapy. Conclusions MS presenting in the hospital setting is more common in KSA than reported previously, and the number of diagnosed cases in increasing. It is therefore an emerging and disabling neurological illness in KSA with clinical characteristics not dissimilar to those in other middle eastern countries. A decrease in the frequency of patients with secondary progressive multiple sclerosis (SPMS) indicates either that more new cases of RRMS are being diagnosed or that adequate treatments of RRMS are preventing the evolution to SPMS. Further larger and populationwide epidemiological and clinical studies with the long-term follow-up of MS patients are required to better assess the clinical spectrum of MS in KSA.
참고문헌 (39)
- Richards RG, "A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models", Health Technol Assess, 6, pp.1~73 (2002)
- Lublin FD, "New multiple sclerosis phenotypic classification", Eur Neurol, 72(Suppl 1), pp.1~5 (2014)
- Weinshenker BG, "Natural history of multiple sclerosis", Ann Neurol, 36(Suppl), pp.S6~S11 (1994)[DOI]
- Miller DH, "Clinically isolated syndromes", Lancet Neurol, 11, pp.157~169 (2012)[DOI]
- Rice CM, "Primary progressive multiple sclerosis: progress and challenges", J Neurol Neurosurg Psychiatry, 84, pp.1100~1106 (2013)[DOI]
- Eriksson M, "Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis", Mult Scler, 9, pp.260~274 (2003)[DOI]
- Scalfari A, "Early relapses, onset of progression, and late outcome in multiple sclerosis", JAMA Neurol, 70, pp.214~222 (2013)[DOI]
- Lublin FD, "Defining the clinical course of multiple sclerosis: the 2013 revisions", Neurology, 83, pp.278~286 (2014)[DOI]
- Evans C, "Incidence and prevalence of multiple sclerosis in the Americas: a systematic review", Neuroepidemiology, 40, pp.195~210 (2013)[DOI]
- Kingwell E, "Incidence and prevalence of multiple sclerosis in Europe: a systematic review", BMC Neurol, 13, pp.128~ (2013)[DOI]
- Alroughani R, "Increasing prevalence and incidence rates of multiple sclerosis in Kuwait", Mult Scler, 20, pp.543~547 (2014)[DOI]
- Deleu D, "Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar", Mult Scler, 19, pp.816~819 (2013)[DOI]
- Kalanie H, "Multiple sclerosis: report on 200 cases from Iran", Mult Scler, 9, pp.36~38 (2003)[DOI]
- Kingwell E, "High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010)", J Neurol, 262, pp.2352~2363 (2015)[DOI]
- Viswanathan S, "Multiple sclerosis in Malaysia: demographics, clinical features, and neuroimaging characteristics", Mult Scler Int, 2013, pp.614716~ (2013)
- Idris MN, "Multiple sclerosis in Sudan: a prospective study of clinical presentation and outcome", Mult Scler, 15, pp.1537~1538 (2009)[DOI]
- Ebers GC, "Environmental factors and multiple sclerosis", Lancet Neurol, 7, pp.268~277 (2008)[DOI]
- Pugliatti M, "Environmental risk factors in multiple sclerosis", Acta Neurol Scand Suppl, 188, pp.34~40 (2008)
- Naeem Z, "Vitamin D deficiency- an ignored epidemic", Int J Health Sci (Qassim), 4, pp.V~VI (2010)
- Pugliatti M, "The worldwide prevalence of multiple sclerosis", Clin Neurol Neurosurg, 104, pp.182~191 (2002)[DOI]
- Polman CH, "Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria", Ann Neurol, 69, pp.292~302 (2011)[DOI]
- Bohlega S, "Multiple sclerosis in the Arabian Gulf countries: a consensus statement", J Neurol, 260, pp.2959~2963 (2013)[DOI]
- Yaqub BA, "Multiple sclerosis in Saudi Arabia", Neurology, 38, pp.621~623 (1988)[DOI]
- Daif AK, "Pattern of presentation of multiple sclerosis in Saudi Arabia: analysis based on clinical and paraclinical features", Eur Neurol, 39, pp.182~186 (1998)[DOI]
- Browne P, "Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity", Neurology, 83, pp.1022~1024 (2014)[DOI]
- Milo R, "Multiple sclerosis: geoepidemiology, genetics and the environment", Autoimmun Rev, 9, pp.A387~A394 (2010)[DOI]
- El-Salem K, "Multiple sclerosis in Jordan: a clinical and epidemiological study", J Neurol, 253, pp.1210~1216 (2006)[DOI]
- Etemadifar M, "Multiple sclerosis in Isfahan, Iran: an update", Mult Scler, 20, pp.1145~1147 (2014)[DOI]
- Tallawy HN, "Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt", Neuropsychiatr Dis Treat, 9, pp.767~771 (2013)
- Shahwar H, "Clinical spectrum of multiple sclerosis at a tertiary care hospital in Pakistan", Pak J Med Sci, 24, pp.221~226 (2008)
- Inshasi J, "Prevalence of multiple sclerosis in Dubai, United Arab Emirates", Int J Neurosci, 121, pp.393~398 (2011)[DOI]
- Alroughani R, "Demographics and clinical characteristics of multiple sclerosis in Kuwait", Eur Neurol, 72, pp.181~185 (2014)[DOI]
- Barkhof F, "Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis", Brain, 120, pp.2059~2069 (1997)[DOI]
- Montalban X, "MRI criteria for MS in patients with clinically isolated syndromes", Neurology, 74, pp.427~434 (2010)[DOI]
- Ontaneda D, "Progressive multiple sclerosis", Curr Opin Neurol, 28, pp.237~243 (2015)[DOI]
- Tanaka K, "Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002", Intern Med, 44, pp.560~566 (2005)[DOI]
- Negreiros AA, "Clinical and epidemiological profile of patients diagnosed with multiple sclerosis in Joao Pessoa, Paraiba, Brazil", Arq Neuropsiquiatr, 73, pp.741~745 (2015)[DOI]
- Akhtar N, "Newly diagnosed multiple sclerosis in state of Qatar", Clin Neurol Neurosurg, 115, pp.1333~1337 (2013)[DOI]
- Thompson AJ, "Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria", Lancet Neurol, 17, pp.162~173 (2018)[DOI]